CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 8-K Event Executive or director change
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 4 Planned sale CEO sold 1,618 shares at $2.08 ($3,361)
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 541 shares at $2.08 ($1,124)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 518 shares at $3.42 ($1,774)
- 4 Planned sale CEO sold 1,555 shares at $3.42 ($5,325)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 11,886 shares at $5.42 ($64,370)
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 6,619 shares at $5.21 ($34,456)
Page 7 of 37 · 731 filings